{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:48:06Z","timestamp":1767649686132,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.tox.2009.10.008","type":"journal-article","created":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T04:27:11Z","timestamp":1255753631000},"page":"204-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Interindividual variations in the efficacy and toxicity of vaccines"],"prefix":"10.1016","volume":"278","author":[{"given":"Chandan","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Moridani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2009.10.008_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1086\/524064","article-title":"Evidence for a heritable predisposition to death due to influenza","volume":"197","author":"Albright","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2009.10.008_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM198909143211103","article-title":"Genetic prediction of nonresponse to hepatitis B vaccine","volume":"321","author":"Alper","year":"1989","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.tox.2009.10.008_bib3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/bmj.304.6834.1075","article-title":"Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine","volume":"304","author":"Benjamin","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.tox.2009.10.008_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.coph.2008.07.013","article-title":"Pharmacogenetics: improving drug and dose selection","volume":"8","author":"Bhathena","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tox.2009.10.008_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/meth.1999.0835","article-title":"Interleukin-1 and interleukin-1 fragments as vaccine adjuvants","volume":"19","author":"Boraschi","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.tox.2009.10.008_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0929-6646(09)60369-7","article-title":"Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century","volume":"108","author":"Chang","year":"2009","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.tox.2009.10.008_bib7","first-page":"1849","article-title":"Association of HLA in immune response to influenza-A immunization","volume":"11","author":"Cunningham-Rundles","year":"1979","journal-title":"Transplant Proc."},{"key":"10.1016\/j.tox.2009.10.008_bib8","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.92.14.6567","article-title":"Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain","volume":"92","author":"Davenport","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tox.2009.10.008_bib9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2007.04.036","article-title":"Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors","volume":"120","author":"Dhiman","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2009.10.008_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/510596","article-title":"Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes","volume":"195","author":"Dhiman","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2009.10.008_bib11","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.vaccine.2008.01.017","article-title":"Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results","volume":"26","author":"Dhiman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2009.10.008_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"Dorig","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.tox.2009.10.008_bib13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tibtech.2008.08.002","article-title":"Structure-based antigen design: a strategy for next generation vaccines","volume":"26","author":"Dormitzer","year":"2008","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.tox.2009.10.008_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0889-8561(02)00055-3","article-title":"Problems and solutions to the development of vaccines in the elderly","volume":"23","author":"Effros","year":"2003","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.tox.2009.10.008_bib15","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm1297-1389","article-title":"Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1","volume":"3","author":"Gauduin","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2009.10.008_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/338014","article-title":"Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine","volume":"185","author":"Gelder","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2009.10.008_bib17","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2009.10.008_bib18","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/eji.1830220733","article-title":"Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype","volume":"22","author":"Hatae","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tox.2009.10.008_bib19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(02)11083-X","article-title":"Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins","volume":"360","author":"Hohler","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2009.10.008_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/hep.20740","article-title":"A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A","volume":"42","author":"Hohler","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2009.10.008_bib21","first-page":"201","article-title":"Cell-mediated and humoral immunity to mumps virus antigen","volume":"94","author":"Hyoty","year":"1986","journal-title":"Acta Pathol. Microbiol. Immunol. Scand. C"},{"key":"10.1016\/j.tox.2009.10.008_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/j.1651-2227.2004.tb03055.x","article-title":"The genetic basis for measles vaccine failure","volume":"93","author":"Jacobson","year":"2004","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.tox.2009.10.008_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0198-8859(02)00741-3","article-title":"The association of class I HLA alleles and antibody levels after a single dose of measles vaccine","volume":"64","author":"Jacobson","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.tox.2009.10.008_bib24","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.vaccine.2007.01.048","article-title":"Studies of twins in vaccinology","volume":"25","author":"Jacobson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2009.10.008_bib25","first-page":"521","article-title":"Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine","volume":"58","author":"Katz","year":"2009","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.tox.2009.10.008_bib26","first-page":"84","article-title":"Expected adverse events in a mass smallpox vaccination campaign","volume":"5","author":"Kemper","year":"2002","journal-title":"Eff. Clin. Pract."},{"key":"10.1016\/j.tox.2009.10.008_bib27","doi-asserted-by":"crossref","first-page":"e3671","DOI":"10.1371\/journal.pone.0003671","article-title":"Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy","volume":"3","author":"Kulkarni","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2009.10.008_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00129785-200404050-00002","article-title":"Human genetics and responses to influenza vaccination: clinical implications","volume":"4","author":"Lambkin","year":"2004","journal-title":"Am. J. Pharmacogenomics"},{"key":"10.1016\/j.tox.2009.10.008_bib29","first-page":"930","article-title":"Progress and obstacles in the development of an AIDS vaccine","volume":"6","author":"Letvin","year":"2006","journal-title":"Nat. Rev."},{"key":"10.1016\/j.tox.2009.10.008_bib30","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0149-2918(08)80048-3","article-title":"Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection","volume":"30","author":"Lieberman-Blum","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tox.2009.10.008_bib31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1086\/315472","article-title":"Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection","volume":"181","author":"MacDonald","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2009.10.008_bib32","first-page":"355","article-title":"Host factors and susceptibility to influenza A infection: the effect of ABO blood groups and HL-A antigens","volume":"39","author":"Mackenzie","year":"1977","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.tox.2009.10.008_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/72318","article-title":"Protection of macaques against vaginal transmission of a pathogenic HIV-1\/SIV chimeric virus by passive infusion of neutralizing antibodies","volume":"6","author":"Mascola","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2009.10.008_bib34","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1586\/14760584.7.9.1405","article-title":"Viral sequence diversity: challenges for AIDS vaccine designs","volume":"7","author":"McBurney","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.tox.2009.10.008_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.immunol.24.021605.090605","article-title":"HIV vaccines","volume":"24","author":"McMichael","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tox.2009.10.008_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/intimm\/8.4.525","article-title":"Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans","volume":"8","author":"Mineta","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.tox.2009.10.008_bib37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1099\/00222615-48-12-1075","article-title":"Sex differences in antibody- and cell-mediated immune response to rubella re-immunisation","volume":"48","author":"Mitchell","year":"1999","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.tox.2009.10.008_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.drudis.2007.04.008","article-title":"The pan-genome: towards a knowledge-based discovery of novel targets for vaccines and antibacterials","volume":"12","author":"Muzzi","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tox.2009.10.008_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.gene.6364051","article-title":"Genetic regulation of immune responses to vaccines in early life","volume":"5","author":"Newport","year":"2004","journal-title":"Genes Immun."},{"key":"10.1016\/j.tox.2009.10.008_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1517\/14622416.5.4.417","article-title":"Variation in vaccine response in normal populations","volume":"5","author":"Ovsyannikova","year":"2004","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.tox.2009.10.008_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/427558","article-title":"Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination","volume":"191","author":"Ovsyannikova","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2009.10.008_bib42","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00251-004-0756-0","article-title":"HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine","volume":"56","author":"Ovsyannikova","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.tox.2009.10.008_bib43","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00251-005-0061-6","article-title":"Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses","volume":"57","author":"Ovsyannikova","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.tox.2009.10.008_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14760584.5.1.33","article-title":"Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines","volume":"5","author":"Ovsyannikova","year":"2006","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.tox.2009.10.008_bib45","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1542\/peds.2007-1575","article-title":"Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine","volume":"121","author":"Ovsyannikova","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.tox.2009.10.008_bib46","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1128\/JVI.75.17.8340-8347.2001","article-title":"Antibody protects macaques against vaginal challenge with a pathogenic R5 simian\/human immunodeficiency virus at serum levels giving complete neutralization in vitro","volume":"75","author":"Parren","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.tox.2009.10.008_bib47","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.tox.2009.10.008_bib48","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0264-410X(01)00346-2","article-title":"Identification of an association between HLA class II alleles and low antibody levels after measles immunization","volume":"20","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2009.10.008_bib49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.clpt.6100415","article-title":"Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics","volume":"82","author":"Poland","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2009.10.008_bib50","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1016\/j.vaccine.2008.06.057","article-title":"Vaccine immunogenetics: bedside to bench to population","volume":"26","author":"Poland","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 4","key":"10.1016\/j.tox.2009.10.008_bib51","doi-asserted-by":"crossref","first-page":"D35","DOI":"10.1016\/j.vaccine.2008.07.065","article-title":"Immunogenetics of seasonal influenza vaccine response","volume":"26","author":"Poland","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2009.10.008_bib52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.tox.2009.10.008_bib53","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nbt1207-1361","article-title":"Bridging the knowledge gaps in vaccine design","volume":"25","author":"Rappuoli","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tox.2009.10.008_bib54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-1-59745-205-2_16","article-title":"Pharmacogenomics in the preclinical development of vaccines: evaluation of efficacy and systemic toxicity in the mouse using array technology","volume":"448","author":"Regnstrom","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tox.2009.10.008_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.tpj.6500080","article-title":"Tetanus antigen modulates the gene expression profile of aluminum phosphate adjuvant in spleen lymphocytes in vivo","volume":"2","author":"Regnstrom","year":"2002","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.tox.2009.10.008_bib56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/gene.2008.80","article-title":"Integrated analysis of genetic and proteomic data identifies biomarkers associated with adverse events following smallpox vaccination","volume":"10","author":"Reif","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.tox.2009.10.008_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0531-5565(98)00060-6","article-title":"Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients","volume":"34","author":"Remarque","year":"1999","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.tox.2009.10.008_bib58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1385\/ENDO:9:2:207","article-title":"Effect of environmental estrogens on IL-1beta promoter activity in a macrophage cell line","volume":"9","author":"Ruh","year":"1998","journal-title":"Endocrine"},{"key":"10.1016\/j.tox.2009.10.008_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20072681","article-title":"The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?","volume":"205","author":"Sekaly","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tox.2009.10.008_bib60","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.vaccine.2009.01.072","article-title":"Genome-based approaches to develop vaccines against bacterial pathogens","volume":"27","author":"Serruto","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2009.10.008_bib61","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1359-6446(04)03095-8","article-title":"Moving forward with reverse vaccinology","volume":"9","author":"Shadan","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tox.2009.10.008_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM197601012940104","article-title":"HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16","volume":"294","author":"Spencer","year":"1976","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.tox.2009.10.008_bib63","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"Tatsuo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tox.2009.10.008_bib64","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.tox.2009.10.008_bib65","first-page":"35","article-title":"Genomics in the development of vaccines","volume":"24","author":"Thomas","year":"2009","journal-title":"Int. Pharm. J."},{"key":"10.1016\/j.tox.2009.10.008_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11908-007-0025-0","article-title":"HIV-1 vaccine development: progress and prospects","volume":"9","author":"Thorner","year":"2007","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.tox.2009.10.008_bib67","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.20142","article-title":"HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination","volume":"39","author":"Wang","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2009.10.008_bib68","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0264-410X(99)00507-1","article-title":"Immunity to influenza in the elderly","volume":"18","author":"Webster","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.tox.2009.10.008_bib69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.provac.2009.07.005","article-title":"Vaxign: a web based vaccine target design program for reverse vaccinology","volume":"1","author":"Xiang","year":"2009","journal-title":"Procedia Vaccinol."},{"key":"10.1016\/j.tox.2009.10.008_bib70","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/S0264-410X(02)00267-0","article-title":"IL-1beta gene polymorphisms influence hepatitis B vaccination","volume":"20","author":"Yucesoy","year":"2002","journal-title":"Vaccine"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X09005125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X09005125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:14:59Z","timestamp":1759533299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X09005125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0300483X09005125"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2009.10.008","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interindividual variations in the efficacy and toxicity of vaccines","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2009.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}